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afford to pay more (or pay anything) for their angiography or bypass 
surgery? How well are they served by the system? In Canada, we 
consider everyone with the clinical indications for coronary angiogra- 
phy or bypass surgery worthy of having the procedure, regardless of 
income. 
HENRY P. KAFKA, MD, FRCPC, FACC 
Lieutenant-Colonel 
Deputy Director 
Cardio-Pulmonary Unit 
National Defence Medical Centre 
Ottawa, Ontario K1A OK6, Canada 
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Reply 
Aday et al. (1) have defined access as those dimensions that describe 
the potential and actual, or realized, entry of a given population into 
the health care delivery system. Access to health care depends on many 
factors, such as race, culture, geographic location, financial and 
insurance status. For numerous reasons, equal access for all citizens to 
health care services in the United States has not yet been achieved. 
Kafka appropriately points out some of the differences between the 
Canadian and the U.S. health care systems and the fact that Canadians 
have "chosen" to emphasize access to primary care for all its citizens, 
apparently at the expense of "prolonged" waiting times for highly 
technical procedures. Certainly these issues must be addressed (as 
emphasized by Ryan [2]): How long a wait is too long? Are there 
negative consequences of too long a wait? Should the procedure in 
question be performed in the first place? However, I think that the 
fundamental issue is more a reflection of societal priorities. Do we as 
a society value health care services for all our citizens? Do we provide 
the financial resources o that all members of society, regardless of 
financial or insurance status, have access to primary and tertiary care 
in a timely manner? Canada has certainly taken a more committed role 
to universal access than has the United States. When the issue of what 
constitutes excessive waiting times are determined, it will be interesting 
to see whether or not Canadians will be willing to provide the financial 
support needed to develop and maintain a rapid-access primary and 
tertiary care system. For now, until we in the United States decide 
whether or not health care is a priority, the debate on how best to 
reform our health care system will continue with more unanswered 
questions than productive change. 
RICHARD J. CARROLL, MD, FACC 
Department of Cardiology 
Loyola University Medical Center 
2160 South First Avenue 
Maywood, Illinois 60153 
Reuse of Balloon Catheters for 
Coronary Angioplasty 
We congratulate Plante et al. (1) for their study in which they 
compared the outcome of balloon angioplasty in two institutions, with 
and without he strategy of reusing balloon catheters. We believe that 
some differences in the results are related to differences in the strategy 
of balloon dilation. It is evident from the report that in the reuse 
center, asmall balloon (smaller than the size of the artery) was used to 
predilate the artery initially. This technique xplains the difference in 
the number of balloon catheters used to dilate a single lesion: 2.4 in the 
reuse center and only 1.2 in the single-use center. The performance of
a reused balloon is not as good as that of a new balloon. However, this 
fact does not explain the observed ifference between centers and the 
number of balloons per lesion. In 90% of patients at the reuse center 
the lesion was crossed with the first attempted balloon catheter, yet 2.3 
balloons were used on average per lesion in these patients. Whether 
small-sized reused balloons were used initially to ensure crossing of 
severe narrowings or whether predilation was the preferred strategy 
regardless of reuse is not clear. 
At our institution 5,676 angioplasty procedures were performed 
over the past 10 years. During this period we were routinely using 
reused balloons, guiding catheters and accessory kits. Our reuse 
protocol is very similar to that described in the current report. We 
recently reported our results in a consecutive series of 2,069 angio- 
plasty procedures (2). A mean of 1.54 lesions were dilated per patient. 
We used an average of 1.95 balloons/patient (1.27 balloons/lesion); the 
number of balloons used per lesion is very similar to that reported 
from the single-use center. Each balloon was used an average of two 
times; thus, for each patient approximately one new and one reused 
balloon were used. Operators at our institution are free to choose a 
new balloon whenever they believe that crossing the lesion might be 
difficult or whenever high risk angioplasty is performed. 
On the basis of our experience, we believe that angioplasty can be 
safely performed with selective use of a reused balloon. Insofar as cost 
calculations are concerned, the cost of a single balloon is not as 
important as the cost of the total number of balloons used per dilated 
lesion. For example, balloon cost per lesion dilation will be greater in 
centers that use 2.4 balloons/lesion with an average of three reuse 
cycles compared with those that use 1.2 balloons/lesion with an average 
of one reuse cycle. The difference is the cost of two reuse cycles. 
A randomized study is needed to examine the safety and cost- 
effectiveness of reusing balloons. Three groups hould he compared: 1) 
no reuse; 2) wide use of reused balloons with predilation of severe 
lesions with small balloons; and 3) selective use of reused balloons. 
YOSEPH ROZENMAN, MD, FACC 
MERVYN S. GOTSMAN, MD, FACC 
Cardiology Department 
Hadassah University Hospital 
P.O. Box 12000 
Ein Kerem 
Jerusalem 91120, Israel 
References 
1. Aday L, Anderson R,Fleming G. Health Care in the U.S.: Equitable for Whom? Beverly 
Hills (CA): Sage Publications, 1980:11. 
2. Ryan TJ. International comparisons of waiting times for cardiovascular procedures: a 
commentary on the long queue. J Am Coil Cardiol 1995;25:564-6. 
References 
1. Plante S, Strauss BH, Goulet G, Watson RK, Chisholm RJ, Reuse of balloon catheters for 
coronary angioplasty: a potential cost-saving strategy? J Am Coil Cardio11994;24:1475-81. 
2. Rozenman Y, Gilon D, Zelingher J, et al. One-stage coronary angiography and angioplasty. 
Am J Cardiol 1995;75:30-3. 
JACC Vol. 26, No. 3 LETTERS TO THE EDITOR 841 
September 1995:838-41 
Reply 
In response to Rozenman and Gotsman regarding our recent report 
(1) on the reuse of angioplasty balloon catheters, I would like to add 
these comments. In the reuse center, the average number of catheters 
used per lesion was two times higher, even if 90% of the lesions were 
successfully crossed with the first-attempted balloon catheter. As 
stated in our report, this difference may be attributable to the poorer 
performance ofreused catheters as well as to the dilation strategy used 
when balloon costs are reduced. Some operators at the reuse center 
used progressive balloon size dilatation because they believed that it 
was a safer technique. In many instances, others preferred to approach 
severe stenoses with small-sized reused balloons because they knew 
from experience that the chances of crossing those lesions with balloon 
catheters matching the vessel diameter were decreased. 
Rozenman et al. (2) recently reported the results of 2,069 angio- 
plasty procedures performed with reused material, with a mean of 1.54 
lesions dilated per patient and 1.95 angioplasty balloon catheters used 
per patient, which represents 1.27 angioplasty balloon catheters/lesion, 
a number very similar to that for the single-use center in our report. 
However, in their practice, each catheter was reused only once, which 
means that 50% of the catheters were new. In our report, however, 
new catheters were used as a first balloon in only 24 lesions, and the 
average number of reuse cycles was 5.2. Furthermore, the average 
number of dilated lesions per patient was higher in the Rozenman et 
al. report han in ours (1,54 vs. 1.25). This fact partly explains why their 
average number of catheters per lesion was reduced because one 
catheter (reused or not) can often be used in the same patient o dilate 
coronary segments of similar diameter. 
I agree with Rozenman and Gotsman that a randomized trial is 
needed to assess the safety and the cost-effectiveness of the reuse 
practice. However, I do not believe that reusing angioplasty material 
offers any direct advantages to patients. Therefore, in the setting of a 
randomized trial, would patients agree to be randomized? 
SYLVAIN PLANTE, MD, FRCP, FACC 
Cardiology Division 
Quebec Heart Institute 
Laval Hospital 
2725 Chemin Ste-Foy 
Ste-Foy, Quebec G1V 4G5, Canada 
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